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Abstract
The Y chromosome, a sex chromosome that only exists in males, has been ignored
in traditional epigenetic association studies for multiple reasons. However, sex dif-
ferences in aging‐related phenotypes and mortality could suggest a critical role of
the sex chromosomes in the aging process. We obtained blood‐based DNA methyla-
tion data on the Y chromosome for 624 men from four cohorts and performed a
chromosome‐wide epigenetic association analysis to detect Y‐linked CpGs differen-
tially methylated over age and cross‐validated the significant CpGs in the four
cohorts. We identified 40–219 significant CpG sites (false discovery rate <0.05)
with >82% of them hypermethylated with increasing age, which is in strong contrast
to the patterns reported on the autosomal chromosomes. Comparing the rate of
change in the Y‐linked DNA methylation across cohorts that represent different age
intervals revealed a trend of acceleration in DNA methylation with increasing age.
The age‐dependent DNA methylation patterns on the Y chromosome were further
examined for their association with all‐cause mortality with results suggesting that
the predominant pattern of age‐related hypermethylation on the Y chromosome is
associated with reduced risk of death.
K E YWORD S
age‐dependent patterns, aging, DNA methylation, mortality, Y chromosome
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Received: 2 January 2019 | Accepted: 2 January 2019
DOI: 10.1111/acel.12907
Aging Cell. 2019;e12907.
https://doi.org/10.1111/acel.12907
wileyonlinelibrary.com/journal/acel | 1 of 8
Epidemiology (Pilot Fund award), Age UK,
The Wellcome Trust Institutional Strategic
Support Fund, The University of Edinburgh,
and The University of Queensland. REM and
IJD are members of the University of
Edinburgh Centre for Cognitive Ageing and
Cognitive Epidemiology (CCACE), which is
supported by funding from the BBSRC, the
Medical Research Council (MRC), and the
University of Edinburgh as part of the cross‐
council Lifelong Health and Wellbeing
Initiative (MR/K026992/1).
1 | INTRODUCTION
The Y chromosome, the sex‐determining chromosome found only in
the male phenotype of the population, contains circa 57 million
DNA base pairs (BP; Million BP: MP; H. Sapiens build: hg38/
GRCh38) and is often neglected in (epi)genetic studies. With its
“small” size, it is only larger in terms of BP than both chromosome
21 (circa 47 MP) and chromosome 22 (circa 51 MP). The Y chromo-
some used to be considered mostly meaningless with a high percent-
age of repetitive and noncoding regions (sometimes referred to as
“genomic deserts”). With improvements in analytical methods and
technologies (Jobling & Tyler‐Smith, 2003, 2017), the chromosome
has become a more popular analysis target. The Y chromosome is
most commonly studied regarding Y‐linked haplogroups (Consortium
YC, 2002; Knijff, 2000; Zerjal et al., 1997), especially within phy-
logeny due to its nature of low recombination and paternal inheri-
tance. Moreover, loss of Y chromosome (LOY) has been observed
with age (Forsberg, 2017) and Y‐chromosomic deletions on specific
regions (Yq11) that are associated with oligozoospermia and
azoospermia phenotypes can cause infertility of different degrees
(Vog et al., 1996).
In comparison with the recent upsurge in omics studies focusing
on autosomal chromosomes, the sex chromosomes are often not
included in analyses, especially within genome‐wide association stud-
ies (GWAS), epigenome‐wide association studies (EWAS), and tran-
scriptome‐wide association studies (TWAS) on complex diseases and
traits (Wise, Gyi, & Manolio, 2013). This is unfortunate because the
sex chromosomes could be influential (directly or indirectly) on cer-
tain diseases with sex differences (Khramtsova et al. 2019). Particu-
larly, in the field of aging research, sex differences have been found
to affect the trajectory of aging phenotypes (Dowling, 2014), aging‐
related diseases such as Alzheimer disease and other dementias
(Mazure & Swendsen, 2016), and mortality (Austad & Fischer, 2016;
Case & Paxson, 2005). Although multiple EWASs have been per-
formed to study the dynamic regulatory patterns of the aging methy-
lome, current literature concerning associations between the Y
chromosome and aging mainly describes LOY and copy number vari-
ants (CNV) (Zhou et al., 2016), which have been reported as far back
as 1972 (Pierre & Hoagland, 1972).
Making use of existing multiple datasets on genome‐wide DNA
methylation in older male subjects, we performed an exploratory Y
chromosome‐wide association study on the aging‐related methylation
changes on the Y chromosome and compared them with those from
the autosomal chromosomes. We replicate findings across datasets
and correlate age‐related methylation changes with all‐cause mortality
and discuss potential implications in the epigenetics of aging.
2 | RESULTS
2.1 | Age patterns of methylation in Y‐linked CpGs
From the four datasets MADT, LASDT1, LSADT2, and LBC1921, we
identified 219, 76, 40, and 169 CpGs displaying age‐dependent
methylation patterns with FDR<0.05, respectively. Among them,
207, 72, 35, and 138 CpGs were hypermethylated over age,
accounting for 95%, 95%, 88%, and 82% of all significant CpGs in
each cohort. There were 12, 4, 5, and 31 CpGs hypomethylated with
age, representing 5%, 5%, 12%, and 18% of all significant CpGs
found in each cohort. The results show a high percentage of hyper-
methylated CpGs with age on the Y chromosome.
2.2 | Cross‐sample/population replication of
significant CpGs
An overall view of the above four sets of CpGs revealed a total of
282 CpGs significantly hypermethylated with FDR <0.05 in at least
one cohort (Supporting Information Table S1), where 139 of the
sites were also significantly hypermethylated in at least one other
cohort with FDR <0.05. For the hypomethylated sites, 48 were sig-
nificant in at least one of the cohorts with FDR <0.05 (Supporting
Information Table S2) but with little validation (N = 3) in any of the
other cohorts with FDR <0.05.
Table 2 presents, for each dataset in the discovery column, the
proportion of significant CpGs replicated across the other three
datasets. In general, hypermethylated CpGs were much more repli-
cated in comparison with hypomethylated CpGs. The 72 and 35
hypermethylated CpGs detected by LSADT2 and LSADT1 had a
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replication rate of over 90% by the MADT cohort. Even the 138
hypermethylated CpGs discovered by the Scottish LBC1921 birth
cohort were replicated with 43% by the Danish MADT cohort. In
the rightmost column of Table 2, we show the proportion of discov-
ery CpGs replicated by any of the three other datasets. It shows
again, the hypermethylated CpGs were much more replicated than
the hypomethylated CpGs. In Table 3, we show detailed information
for 7 CpGs that are present in all four cohorts with FDR <0.05. All
of them are hypermethylated with increasing age. Among the 7
CpGs, 5 are linked to functional genes or pseudogenes at the pro-
moter regions.
2.3 | Accelerated rate of hypermethylation in high
age‐groups
By plotting the coefficients of the significant hypermethylated CpGs
over Y chromosome position (Figure 1), we see a tendency of
increased hypermethylation profiles with increased age. We
smoothed the regression coefficients for age (the rate of change)
using locally weighted scatterplot smoother (Jacoby, 2000) (LOESS,
α = 0.5), with residual standard errors of 0.51, 1.57, 0.917, and
1.772, for MADT, LSADT1, LSADT2, and LBC1921, respectively.
These lines clearly demonstrate a trend of a higher magnitude of
regression coefficients for hypermethylation for cohorts of higher
mean ages. More specifically, LBC1921 (mean age: 88.51) has higher
coefficient values compared with MADT (mean age: 66.73), LSADT1
(mean age: 79.34), and LSADT2 (mean age: 81.69). The lines for
LSADT1 and LSADT2 are intertwined but still notably higher com-
pared to the line of MADT.
Figure 2 displays the box plots for cohort age (a) and for the
regression coefficients of significantly hypermethylated CpGs by
dataset (b). We see a tendency of higher age with higher methyla-
tion level. The tendency is seen when looking at Figure 2c. Here, we
see that the mean increase in age of 133% (factor 1.33, mean age
66.73–88.51 years) corresponds to the accelerated hypermethylation
values by 260% percent (mean coefficients of 1.31–3.40).
Among the significant CpGs (FDR <0.05), 7 were present in all
four cohorts (Table 3). Again, we checked how the coefficient of
these corresponded to findings above. We ranked the coefficient of
each site from each cohort to numbers between 1 and 4, where 1
was the highest value and 4 was the lowest. We saw that for all but
one sites, LBC1921 had the highest value (score: 1). For MADT, all
sites had the smallest value (score: 4). For LSADT1 and LSADT2, the
scores were all either 2 or 3, except for a single site having score 1.
Again here, we are able to reveal how the higher ages in the cohorts
correspond to higher coefficients for the 7 CpGs.
By performing the Wilcoxon rank‐sum test (also known as
Mann–Whitney–Wilcoxon (MWW) or U test) on all sites where the
coefficients in all cases were hypermethylated (N = 125), revealed
the same conclusions as above. The 125 sites were picked out on
the basis that only the sites that at least one of them were signifi-
cantly associated with age (FDR<0.05) in at least one cohort but
had positive regression coefficients (i.e., increased methylation over
age) for all four datasets. With an H0 = no difference in coeffi-
cients between the cohorts (where the main difference of the
cohorts is their age), the test results are produced in Table 4. For
all tests except the comparison between LSADT1 and LSADT2
(p = 0.80), a significant difference was observed, with p = 2.7832e‐
06 for comparing LBC1921 with MADT. We can conclude that
there are significant differences in the coefficients (i.e., the rate of
change) between older and younger cohorts, as suggested by Fig-
ures 1 and 2.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
0
2,0
00
,00
0
4,0
00
,00
0
6,0
00
,00
0
8,0
00
,00
0
10
,00
0,0
00
12
,00
0,0
00
14
,00
0,0
00
16
,00
0,0
00
18
,00
0,0
00
20
,00
0,0
00
22
,00
0,0
00
24
,00
0,0
00
26
,00
0,0
00
Y  chromosome position
R
eg
re
ss
io
n 
co
ef
fic
ie
nt
Dataset (mean age)
LBC1921 (88.51)
LSADT1 (81.69)
LSADT2 (79.43)
MADT (66.73)
F IGURE 1 Plotted coefficients of the
discovery analysis over their chromosome
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2.4 | Relationship with mortality
The LBC1921 birth cohort contains samples of older ages with infor-
mation on mortality available. This enables us to compare the associ-
ation of age‐related CpGs on the risk of death. Among the 169 age‐
associated CpGs, about half (74 CpGs, 44%) have p < 0.05 in the
survival analysis using Cox regression (Supporting Information
Table S3). In Figure 3, we display the coefficients from the Cox
regression model against the coefficients on age (the rate of change)
for methylation. CpGs significantly hyper‐ or hypomethylated with
age (FDR<0.05 for empty dots; the larger the dots, the higher the
significance level) also tend to be significantly associated with mor-
tality (red dots p < 0.05 from Cox model). The relationship is domi-
nated by CpGs hyper‐ or hypomethylated with age (large dots) that
are associated with a lower hazard of death (negative coefficients
from Cox model for hypermethylated CpGs in the bottom‐right panel
while positive coefficients from Cox model for hypomethylated CpGs
in the top‐left panel). The collective association with mortality (indi-
cated by incremental R2) by age‐associated CpGs is shown in Sup-
porting Information Figure S1 where a PMS based on a list of top
30 CpGs best fits to the mortality data with a p‐value of 9.59e‐03
and adjusted R2 of 0.035. Interestingly, the regression coefficient for
all PMSs is negative (Supporting Information Table S4) indicating a
negative correlation with mortality.
3 | DISCUSSION
By focusing on male‐only samples, we were able to analyze the age
pattern of Y‐linked DNA methylation in older people. We identified
significant CpG sites that change their methylation levels across
ages. Different from the reported age‐related methylation patterns
dominated by decreased methylation over increasing ages (Johans-
son, Enroth, & Gyllensten, 2013; Li et al., 2017; Marttila et al.,
2015), the Y‐linked DNA methylation is characterized by increased
methylation with increasing age, accounting for over 80% or 90% of
all the significant age‐associated CpGs. As shown by Figure 3, the
CpGs hypermethylated with increasing age nearly all have negative
coefficients from the Cox model indicating an association with
longer survival by age‐related methylation changes. For the small
group of CpGs with increased hazard of death when methylation
goes up, their methylation levels are in fact decreased with increas-
ing age meaning nonincreased or even decreased risk of death by
their age‐related methylation patterns. This is further supported by
the Cox model for PMS with a negative coefficient showing that
increased score of multiple age‐related CpGs (mostly hypermethy-
lated with age) reduces the risk of death. We postulate that the
observed age‐associated hypermethylation on the Y chromosome
could represent an active response to the aging process that helps
to maintain male survival at high ages.
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F IGURE 2 Plots displaying accelerated increase in DNA methylation by significantly hypermethylated CpGs (FDR <0.05) in the four cohorts
ordered by increasing mean age. The boxplots in 2a and 2b show the distribution of sample ages and regression coefficients of
hypermethylated CpGs in each cohort. Acceleration in DNA hypermethylation with increasing age is clearly illustrated by plotting, for each
cohort, the means of ages and means of regression coefficients normalized by MADT (2c)
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The detected age‐associated hypermethylation on the Y chromo-
some is further consolidated by our cross‐cohort replication as
shown in Table 2. High replication rates were observed across the
datasets for hypermethylated CpGs while that for the hypomethy-
lated CpGs were mostly low. This contrast suggests that the
observed overwhelming pattern of Y‐linked hypermethylation could
represent a striking difference in the age‐related epigenetic control
over sex and autosomal chromosomes as the age‐associated methy-
lation patterns on autosomal chromosomes are dominated by
reduced methylation with increasing age (Li et al., 2017). We have
recently compared the age‐associated CpGs with mortality‐associ-
ated CpGs on autosomal chromosomes found in the LBC1921 birth
cohort and found very limited overlap (about 10% of the age‐associ-
ated CpGs) between them although the overlap is significantly differ-
ent from random (unpublished results). Most importantly, the
overlapping CpGs are dominated by those age‐related methylation
patterns help to reduce mortality. Different from the autosomal
chromosomes, the high overlap (44%) between age‐ and mortality‐
associated CpGs on the Y chromosome (Figure 3) highlights its high
importance in successful aging in males.
Among the 5 annotated genes in Table 3, increased expression
of NLGN4Y has been associated with autism (Ross, Tartaglia, Merry,
Dalva, & Zinn, 2015) and expression of DDX3Y may modulate
neuronal differentiation (Vakilian et al., 2015). A recent study
reported that the expression of the TBL1Y gene plays an important
role in cardiac differentiation (Meyfour et al., 2017). The other gene
in Table 3 (TTTY23, TTTY20, LOC100101121, or TTTY23B) is all
nonprotein coding genes involved perhaps in the regulatory domain.
Although current literature on these genes is limited and may not be
directly linked with aging and mortality, their biological roles merit
further investigations.
The Y chromosome accounts for about 2% of the total length of
human genetic materials. However, the number of Y‐linked CpGs on
the Illumina 450 K array (416 CpGs) is less than 0.1% of the total
number of CpGs on the array (485,242 CpGs). This means that the
CpGs for the Y chromosome are highly underrepresented. This can
be due to the fact that the Y chromosome is a gene‐poor area (75–
80 genes), in comparison with the number of genes carried by chro-
mosome 20 (500–600 genes) which is about the same size. Compar-
ing the number of CpGs on Y chromosome and chromosome 20
(10,383 CpGs), the proportion of Y‐linked CpGs is very much limited.
This presents an obvious limitation of our study, and as such, our
results should be interpreted with caution. We hope that future
studies using high capacity design or methylation sequencing tech-
nique will help to validate our findings and uncover the impact of Y
chromosome on male aging.
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F IGURE 3 Scatterplot displaying
relationship between age‐related rate of
change in DNA methylation and mortality.
The empty dots are CpGs significantly
methylated with age (FDR <0.05, the
larger the dots the higher the statistical
significance). The red dots are CpGs
associated with mortality with p < 0.05 in
the Cox regression model. The figure
shows that age‐associated CpGs
predominantly contribute to reduced risk
of death
TABLE 1 Cohort‐specific characteristics ordered by mean age
MADT LSADT2 LSADT1 LBC1921 Total
N (males) 266 72 48 238 624
Mean age (year) ± SD 66.73 ± 6.18 79.43 ± 4.08 81.69 ± 5.28 88.51 ± 4.74 77.66 ± 11.2
Age min/max (year) 56.99–79.87 74.33–87.75 74.66–89.59 79.01–94.97 56.99–94.97
Country of origin Denmark Denmark Denmark Scotland
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4 | MATERIALS AND METHODS
4.1 | Study populations and samples
We analyzed Y chromosome data on four cohorts of middle‐ and
older‐aged subjects consisting of Middle‐Aged Danish Twins (MADT)
(Gaist et al., 2000), Longitudinal Study of Aging Danish Twins
(LSADT1, LSADT2) (Christensen, Holm, Mcgue, Corder, & Vaupel,
1999), and Lothian Birth Cohort of 1921 (LBC1921) (Deary, Gow,
Pattie, & Starr, 2011). All four cohorts utilized DNA isolated from
whole‐blood samples from individuals between the age of 56 and 95
which have been processed using the Illumina HumanMethyla-
tion450 BeadChip or 450 K array (Illumina, Inc., San Diego, CA,
USA). For this study, only male participants (N = 624), probes corre-
sponding to the CpGs located on the Y chromosome (N = 416), and
the latest wave sample of each participant from LBC1921 were
used. Table 1 outlines the basic cohort characteristics.
4.2 | Preprocessing and quality control (QC)
Before statistical analysis, the three Danish cohorts (MADT, LSADT1,
and LSADT2) were normalized internally only by their Y‐linked CpGs
(N = 416). This was done, using the minfi R package (Aryee et al.,
2014) through subset‐quantile within array normalization (SWAN)
(Maksimovic, Gordon, & Oshlack, 2012). The Scottish (LBC1921)
cohort was already normalized using this package, but for the whole
genome and was additionally adjusted for a minor batch effect
revealed by principal component analysis (PCA) using the ComBat
(Johnson, Li, & Rabinovic, 2007) function from the sva R package
(Leek, Johnson, Parker, Jaffe, & Storey, 2012). Subsequently, we per-
formed QC by removing probes with an overall sum of 10 or more
cross‐reactive targets (N = 18) (Y‐a et al., 2013). No probes with
detection p > 0.01, no‐signaling, polymorphic probes with European
allele frequency at least 1% or more than 5% percent missing values
were found. A total of 398 CpGs remained after preprocessing. For
each CpG, methylation, β value was calculated as M/(M + U) with M
and U for the methylated and unmethylated signal intensities. Before
statistical modeling, methylation β values were converted into M val-
ues for better statistical properties by logit transformation.
4.3 | CpG‐based association tests
The CpG‐based age association tests were modeled using linear
regression models. For the Danish twin samples, twin pairing was
included as a random factor in a mixed effect model. The regression
analysis adjusted for blood cell‐type composition (CD8T, CD4T, nat-
ural killer cell (NK), B cell, monocyte, and granulocyte) estimated
using Houseman's method (Houseman et al., 2012) implemented in
TABLE 2 Cross‐cohort replication for each set of hyper‐ and
hypomethylated CpGs. Rows indicate discovery cohorts (N: the
number of significant CpGs with FDR <0.05), and column indicate
replication cohorts with percentages in the table showing the
replication rate. The last column is proportion of discovery CpGs
replicated by at least one replication cohort
Replication
Discovery MADT LSADT2 LSADT1 LBC1921 Any
Hypermethylated
MADT
(N = 207)
31.40% 15.46% 28.50% 57.00%
LSADT2
(N = 72)
90.28% 30.56% 27.78% 95.83%
LSADT1
(N = 35)
91.43% 62.86% 8.57% 94.29%
LBC1921
(N = 138)
42.75% 14.49% 2.17% 46.38%
Hypomethylated
MADT
(N = 12)
0.00% 8.33% 8.33% 16.67%
LSADT2
(N = 4)
0.00% 0.00% 25.00% 25.00%
LSADT1
(N = 5)
20.00% 0.00% 0.00% 20.00%
LBC1921
(N = 31)
3.23% 3.23% 0.00% 6.45%
TABLE 3 The 7 CpGs significantly hypermethylated in all four datasets (FDR <0.05)
Cross‐cohort hypermethylated CpGs (N = 7, FDR <0.05) Illumina 450 K annotationa
CpG MADTcoef
b LSADT2coef
b LSADT1coef
b LBC1921coef
b Gene (Name) Gene (Group) CpG Island
cg03055837 0.897143 (4) 1.008964 (3) 1.399633 (2) 2.602283 (1) NLGN4Y TSS1500 N_Shore
cg00311963 0.89143 (4) 0.988388 (3) 1.17261 (2) 1.917789 (1) LOC100101121;TTTY23 TSS1500 S_Shore
cg00679624 0.836824 (4) 1.03516 (3) 1.069887 (2) 2.545285 (1) Island
cg14180491 1.133525 (4) 2.143094 (2) 2.780263 (1) 2.068691 (3) DDX3Y 5'UTR;1stExon Island
cg01707559 1.194551 (4) 1.733023 (2) 1.228877 (3) 4.47433 (1) TBL1Y TSS200 Island
cg18188392 1.989856 (4) 2.556912 (3) 2.715966 (2) 3.89269 (1) Island
cg06636270 1.017389 (4) 2.124417 (2) 1.581355 (3) 2.837249 (1) TTTY20 TSS1500 N_Shore
aUCSC annotation, University of California, Santa Cruz. bThe coefficients are based on regression coefficients for age, and the number in parenthesis
indicates order ranked from highest to lowest coefficient (1–4).
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the R package minfi for the Danish twin data and R package celltype-
s450 for the LBC1921 data.
The model for the twin cohorts was defined as:
DNAmCpG ¼ β0 þ β1age þ β2CD8T þ β3CD4T
þ β4NK þ β5Bcellþ β6Mono
þ β7Gram þ 1jTwinPairID
while for LBC1921, the model was defined as:
DNAmCpG ¼ β0 þ β1age þ β2CD8T þ β3CD4T þ β4NK
þ β5Bcell þ β6Mono þ β7Gram
For both, DNAm is methylation level for a CpG, that is, the
methylation M value. The coefficient β1of these regression models
captures the mean pattern of DNAm changes over age or the rate
of change in DNA methylation by age. Multiple testing was adjusted
by calculating the false discovery rate (FDR, Benjamani–Hochberg;
Benjamini & Hochberg, 1995), and CpGs with FDR <0.05 were
defined as significant.
Besides analyzing the age‐dependent methylation patterns of Y‐
linked CpGs, we also perform survival analysis to estimate the effect
of DNA methylation on the risk of death in the LBC1921 samples
(N = 238, death = 151) using the Cox proportional hazard model,
hðtÞ ¼ h0ðtÞ exp β1DNAm þ β2ageð Þ
here, t is the survival time (from age at blood sampling to death or
to last follow‐up if censored), h(t) is the hazard function, and h0(t) is
the baseline hazard function. The effect of DNA methylation on sur-
vival is adjusted for age at blood sampling.
4.4 | Polygenic methylation score (PMS)
To summarize the effect of age‐associated Y‐linked CpGs on mortal-
ity, we use PMS as introduced by Linnér et al. (2017). For a list of q
age‐associated CpGs selected using a significance cutoff, the PMS
for a sample j is calculated as the sum of their coefficients for age
(β) multiplied by methylation levels of corresponding CpGs (DNAm),
PMSj ¼ ∑qi¼1βðiÞ DNAmði; jÞ. Effect on mortality for the calculated
PMS is assessed by including it as a variable in the Cox regression
model together with individual age as a covariate for adjustment.
The predictive power of PMS is evaluated by the incremental coeffi-
cient of determination (incremental R2) calculated as the difference
in R2 (pseudo R2) between the Cox model fitted with PMS and age
and the model with age only.
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